RicChoimi
11-08-2022, 02:29 AM
We updated the results of our previous meta analysis of benefits and harms of tamoxifen and raloxifene for 2 outcomes mortality and endometrial cancer for raloxifene with new data using methods described in previous publications 13 doxycycline immunosuppression ([Only registered and activated users can see links])